Added another 90K shares today! I’m excited for the In vivo/clinical studies. With half of the equation (safety) already solved, we simply await the efficacy results. If Brilacidin achieves only 50% efficacy, it will be the gold standard of therapeutics for COVID19. Of course, we believe that it will be significantly higher! GLTAL.